Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.1961 | 1 | 0.5 |
Loa Loa (eye worm) | TK/FAK protein kinase | 0.0268 | 0.0081 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0255 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.1961 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0255 | 0 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0255 | 0 | 0.5 |
Echinococcus multilocularis | protein tyrosine kinase | 0.0265 | 0.0062 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0268 | 0.0081 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.1961 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0255 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.1961 | 1 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.1961 | 1 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.1961 | 1 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0265 | 0.0062 | 0.5 |
Echinococcus granulosus | protein tyrosine kinase | 0.0265 | 0.0062 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.1961 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0255 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 49.5 uM | Inhibition of GST-tagged HDM2 (unknown origin) assessed as p53 ubiquitination by Western blot analysis | ChEMBL. | 24113239 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.